Literature DB >> 15078962

A glycine-rich bovine herpesvirus 5 (BHV-5) gE-specific epitope within the ectodomain is important for BHV-5 neurovirulence.

A Al-Mubarak1, Y Zhou, S I Chowdhury.   

Abstract

The bovine herpesvirus 5 (BHV-5) gE ectodomain contains a glycine-rich epitope coding region (gE5 epitope), residues 204 to 218, that is significantly different from the corresponding gE region of BHV-1. Deletion of the gE epitope significantly reduced the neurovirulence of BHV-5 in rabbits. Pulse-chase analyses revealed that the epitope-deleted and wild-type gE were synthesized as N-glycosylated endoglycosidase H-sensitive precursors with approximate molecular masses of 85 kDa and 86 kDa, respectively. Like the wild-type gE, epitope-deleted gE complexed with gI and was readily transported from the endoplasmic reticulum. Concomitantly, the epitope-deleted and wild-type gE acquired posttranslational modifications in the Golgi leading to an increased apparent molecular mass of 93-kDa (epitope-deleted gE) and 94-kDa (wild-type gE). The kinetics of mutant and wild-type gE processing were similar, and both mature proteins were resistant to endoglycosidase H but sensitive to glycopeptidase F. The gE epitope-deleted BHV-5 formed wild-type-sized plaques in MDBK cells, and the epitope-deleted gE was expressed on the cell surface. However, rabbits infected intranasally with gE epitope-deleted BHV-5 did not develop seizures, and only 20% of the infected rabbits showed mild neurological signs. The epitope-deleted virus replicated efficiently in the olfactory epithelium. However, within the brains of these rabbits there was a 10- to 20-fold reduction in infected neurons compared with the number of infected neurons within the brains of rabbits infected with the gE5 epitope-reverted and wild-type BHV-5. In comparison, 70 to 80% of the rabbits exhibited severe neurological signs when infected with the gE5 epitope-reverted and wild-type BHV-5. These results indicated that anterograde transport of the gE epitope-deleted virus from the olfactory receptor neurons to the olfactory bulb is defective and that, within the central nervous system, the gE5 epitope-coding region was required for expression of the full virulence potential of BHV-5.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15078962      PMCID: PMC387723          DOI: 10.1128/jvi.78.9.4806-4816.2004

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  42 in total

Review 1.  Infection and spread of alphaherpesviruses in the nervous system.

Authors:  L W Enquist; P J Husak; B W Banfield; G A Smith
Journal:  Adv Virus Res       Date:  1998       Impact factor: 9.937

2.  Role of envelope protein gE endocytosis in the pseudorabies virus life cycle.

Authors:  R S Tirabassi; L W Enquist
Journal:  J Virol       Date:  1998-06       Impact factor: 5.103

3.  Specific detection of shedding and latency of bovine herpesvirus 1 and 5 using a nested polymerase chain reaction.

Authors:  S E Ashbaugh; K E Thompson; E B Belknap; P C Schultheiss; S Chowdhury; J K Collins
Journal:  J Vet Diagn Invest       Date:  1997-10       Impact factor: 1.279

4.  Mutation of the YXXL endocytosis motif in the cytoplasmic tail of pseudorabies virus gE.

Authors:  R S Tirabassi; L W Enquist
Journal:  J Virol       Date:  1999-04       Impact factor: 5.103

5.  Neuropathology of bovine herpesvirus type 5 (BHV-5) meningo-encephalitis in a rabbit seizure model.

Authors:  S I Chowdhury; B J Lee; D Mosier; J H Sur; F A Osorio; G Kennedy; M L Weiss
Journal:  J Comp Pathol       Date:  1997-11       Impact factor: 1.311

6.  Characterization of pseudorabies virus mutants expressing carboxy-terminal truncations of gE: evidence for envelope incorporation, virulence, and neurotropism domains.

Authors:  R S Tirabassi; R A Townley; M G Eldridge; L W Enquist
Journal:  J Virol       Date:  1997-09       Impact factor: 5.103

7.  Intracellular traffic of herpes simplex virus glycoprotein gE: characterization of the sorting signals required for its trans-Golgi network localization.

Authors:  A Alconada; U Bauer; B Sodeik; B Hoflack
Journal:  J Virol       Date:  1999-01       Impact factor: 5.103

8.  Endocytosis and recycling of varicella-zoster virus Fc receptor glycoprotein gE: internalization mediated by a YXXL motif in the cytoplasmic tail.

Authors:  J K Olson; C Grose
Journal:  J Virol       Date:  1997-05       Impact factor: 5.103

9.  The herpes simplex virus gE-gI complex facilitates cell-to-cell spread and binds to components of cell junctions.

Authors:  K S Dingwell; D C Johnson
Journal:  J Virol       Date:  1998-11       Impact factor: 5.103

10.  Characterization of domains of herpes simplex virus type 1 glycoprotein E involved in Fc binding activity for immunoglobulin G aggregates.

Authors:  G Dubin; S Basu; D L Mallory; M Basu; R Tal-Singer; H M Friedman
Journal:  J Virol       Date:  1994-04       Impact factor: 5.103

View more
  12 in total

Review 1.  Olfactory transmission of neurotropic viruses.

Authors:  Isamu Mori; Yukihiro Nishiyama; Takashi Yokochi; Yoshinobu Kimura
Journal:  J Neurovirol       Date:  2005-04       Impact factor: 2.643

Review 2.  The Olfactory Bulb: An Immunosensory Effector Organ during Neurotropic Viral Infections.

Authors:  Douglas M Durrant; Soumitra Ghosh; Robyn S Klein
Journal:  ACS Chem Neurosci       Date:  2016-04-08       Impact factor: 4.418

Review 3.  Pathogens penetrating the central nervous system: infection pathways and the cellular and molecular mechanisms of invasion.

Authors:  Samantha J Dando; Alan Mackay-Sim; Robert Norton; Bart J Currie; James A St John; Jenny A K Ekberg; Michael Batzloff; Glen C Ulett; Ifor R Beacham
Journal:  Clin Microbiol Rev       Date:  2014-10       Impact factor: 26.132

4.  Glycoprotein D of bovine herpesvirus 5 (BoHV-5) confers an extended host range to BoHV-1 but does not contribute to invasion of the brain.

Authors:  Evgeni Gabev; Kurt Tobler; Carlos Abril; Monika Hilbe; Claudia Senn; Marco Franchini; Gabriella Campadelli-Fiume; Cornel Fraefel; Mathias Ackermann
Journal:  J Virol       Date:  2010-03-10       Impact factor: 5.103

5.  The Us9 gene of bovine herpesvirus 1 (BHV-1) effectively complements a Us9-null strain of BHV-5 for anterograde transport, neurovirulence, and neuroinvasiveness in a rabbit model.

Authors:  S I Chowdhury; S Mahmood; J Simon; A Al-Mubarak; Y Zhou
Journal:  J Virol       Date:  2006-05       Impact factor: 5.103

6.  In the absence of glycoprotein I (gI), gE determines bovine herpesvirus type 5 neuroinvasiveness and neurovirulence.

Authors:  A Al-Mubarak; S I Chowdhury
Journal:  J Neurovirol       Date:  2004-08       Impact factor: 2.643

7.  A bovine herpesvirus type 1 mutant virus specifying a carboxyl-terminal truncation of glycoprotein E is defective in anterograde neuronal transport in rabbits and calves.

Authors:  Z F Liu; M C S Brum; A Doster; C Jones; S I Chowdhury
Journal:  J Virol       Date:  2008-05-14       Impact factor: 5.103

8.  Brain-derived neurotrophic factor is down regulated after bovine alpha-herpesvirus 5 infection in both wild-type and TLR3/7/9 deficient mice.

Authors:  Daniele Gonçalves DA Silva; Iracema Luisa Quintino de Carvalho; Eliana Cristina de Brito Toscano; Beatriz Álvares da Silva Senra Santos; Bruna da Silva Oliveira; Marco Antônio Campos; Flávio Guimarães da Fonseca; Quezya Mendes Camargos; Gabriela Ferreira de Sousa; Marcelo Vidigal Caliari; Antônio Lúcio Teixeira; Aline Silva de Miranda; Milene Alvarenga Rachid
Journal:  J Vet Med Sci       Date:  2020-12-07       Impact factor: 1.267

9.  Bovine herpesvirus type 1 (BHV-1) UL49.5 luminal domain residues 30 to 32 are critical for MHC-I down-regulation in virus-infected cells.

Authors:  Huiyong Wei; Ying Wang; Shafiqul I Chowdhury
Journal:  PLoS One       Date:  2011-10-26       Impact factor: 3.240

10.  Rapid identification of novel immunodominant proteins and characterization of a specific linear epitope of Campylobacter jejuni.

Authors:  Sebastian Hoppe; Frank F Bier; Markus von Nickisch-Rosenegk; Markus V Nickisch-Rosenegk
Journal:  PLoS One       Date:  2013-05-29       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.